Cargando…

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib

A 52-year-old man with a past medical history of chronic myeloid leukemia (CML) in remission developed progressive shortness of breath over a two-month period. He was initially treated with dasatinib for four years, until developing pulmonary arterial hypertension (PAH) with pleural effusions. His s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seegobin, Karan, Babbar, Amit, Ferreira, Jason, Lyons, Brittany, Cury, James, Seeram, Vandana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703128/ https://www.ncbi.nlm.nih.gov/pubmed/28914582 http://dx.doi.org/10.1177/2045893217733444

Ejemplares similares

Dasatinib induced pleural effusions - Reply
por: AJ Abdulla, Mohammad, et al.
Publicado: (2020)

Dasatinib-Induced Pleural and Pericardial Effusions
por: Hailan, Yousef M, et al.
Publicado: (2021)

Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)

A Large Pleural Effusion following Abdominal Aortic Surgery
por: Ramsaran, Vinoo K., et al.
Publicado: (2015)

Dasatinib-induced pleural effusion: Chylothorax, an option to consider
por: Ferreiro, Lucía, et al.
Publicado: (2016)

Dasatinib: Chylothorax and right pleural effusion: case report
Publicado: (2019)

Dasatinib: Aggravation of bilateral pleural effusion: case report
Publicado: (2022)

Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
por: Liu, Qiuying (Selina), et al.
Publicado: (2021)

Recurrent Chylous Pleural Effusions in a Patient Treated With Dasatinib
por: Nasir, Syed Alishan, et al.
Publicado: (2022)

Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
por: Moguillansky, Natalia I., et al.
Publicado: (2017)

Pleural Effusion Secondary to Dasatinib Following Allogenic Hematopoietic Stem Cell Transplantation
por: Alrubaye, Riyadh R., et al.
Publicado: (2021)

Exacerbation of pleural effusion in a dasatinib-treated patient during the perioperative period
por: Hasegawa, Takayuki, et al.
Publicado: (2022)

Dasatinib: COVID-19 pneuminia, febrile neutropenia, pancytopenia and pleural effusion: case report
Publicado: (2020)

Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase
por: Takatsuka, Ibuki, et al.
Publicado: (2022)

Rare cause of paradoxical worsening of pleural effusion in a patient with tuberculosis
por: Duraikannan, Paramasivan, et al.
Publicado: (2017)

The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases
por: Ozanne, James, et al.
Publicado: (2015)

Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia
por: Nakaya, Aya, et al.
Publicado: (2018)

A case of Sjögren's syndrome with worsening of pleural effusion due to steroid discontinuation
por: Usami, Osamu
Publicado: (2021)

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation
por: Uz, B., et al.
Publicado: (2011)

Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
por: Cortes, Jorge E., et al.
Publicado: (2016)

Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high‐performance liquid chromatography–Photodiode array detection
por: Yokoyama, Yuta, et al.
Publicado: (2022)

Incident pulmonary arterial hypertension associated with Bosutinib
por: Yo, Shaun, et al.
Publicado: (2020)

Dasatinib induced pleuro-pericardial effusion
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia
por: Hughes, Timothy P., et al.
Publicado: (2019)

An uncommon cause of pleural effusion
por: Panjwani, Amit, et al.
Publicado: (2019)

An interesting case of undiagnosed pleural effusion
por: Panjwani, Amit, et al.
Publicado: (2017)

Pleural Effusion
por: Gray, Frank D.
Publicado: (1963)

Pleural Effusion
por: Brunton, T. Lauder
Publicado: (1898)

Pleural Effusion
por: Sherding, Robert G., et al.
Publicado: (2006)

Pleural Effusions
Publicado: (1877)

Comparison of the Efficacy of Light’s Criteria With Serum-Effusion Albumin Gradient and Pleural Effusion Glucose
por: Sharma, Karan, et al.
Publicado: (2023)

Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015)

Metastatic ductal adenocarcinoma of the breast presenting with pericardial effusion—Challenges in the diagnosis of breast cancer
por: Chahin, Michael, et al.
Publicado: (2019)

Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
por: Chandel, Abhimanyu, et al.
Publicado: (2021)

Dasatinib-induced Pulmonary Hypertension
por: Tamura, Yudai, et al.
Publicado: (2022)

Filarial pleural effusion
por: Gowrinath, K.
Publicado: (2011)

Tuberculous Pleural Effusion
por: Schlesinger, Shira A., et al.
Publicado: (2012)

Filariasis and pleural effusion
por: Wiwanitkit, Somsri, et al.
Publicado: (2013)

Encysted Pleural Effusions
por: Viswanathan, R.
Publicado: (1946)

Cholesterol Pleural Effusion
por: Curran, Thomas M.
Publicado: (1948)

Cannot write session to /tmp/vufind_sessions/sess_qc7htb8j0tul7rprlqjdg4k8t6